Dr Lorna Pender

Dr. Lorna Pender is currently serving as the Director of Scientific & Government Affairs at Revvity since August 2024 and as an Expert Patient Board Member at St Johns Institute of Dermatology, Kings College London. Previous experience includes leading global patient engagement initiatives at Clinigen from October 2022 to August 2024 and holding the position of Senior Medical Advisor at Novo Nordisk from September 2021 to October 2022. Dr. Pender has extensive expertise in medical affairs, having worked in various roles including Senior MSL at BIAL, MSL Manager at Gedeon Richter Pharma GmbH, and UK Medical Science Liaison at Portola Pharmaceuticals. Additional positions include Medical Science Liaison at GSK and Medical Manager at Kyowa Kirin International plc. Dr. Pender's educational background includes an MBChB in Medicine and a BSc Hons in Sports Medicine, both from the University of Glasgow.